Calcutta HC Rejects Reliance on ‘Vedic Mantras’, Commutes Death Sentence in Wife’s Murder Case  ||  Tripura High Court Pulls Up State Over Failure to Implement Supreme Court's Open Prison Directions  ||  Calcutta HC Upholds Life Term for Father who Raped Minor Daughter, Causing Pregnancy  ||  Karnataka HC Directs Trial Courts, Police to Furnish S.164 of CrPC Statement Copies to Accused  ||  P&H HC: Immigration Fraud by Consultancies is a Growing Menace, Denies Pre-Arrest Bail Leniency  ||  CCPA Fines Rs. 1 Lakh Penalty on United Biscuits over Misleading ‘Wholewheat’ Claims  ||  Bombay HC Permits OTT Release of Hindi Film ‘Bandar’ Subject to Appropriate Disclaimers  ||  Gujarat HC Grants Bail to Marriage Bureau Owner, Finds No Link to Alleged ‘Looteri Dulhan’ Gang  ||  Calcutta HC: Minor’s Consent has No Mitigating Effect in POCSO Sexual Assault Cases  ||  Orissa HC Commutes Death Sentence, Says Emotion Cannot Override Established Law    

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT   SELLING OF REMDESIVIR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved